Abstract
The tumor suppressor transcription factor IRF-1 inhibits cell growth. In this report we show that IRF-1 also induces apoptosis of highly transformed and tumorigenic cell lines. This activity of IRF-1 is demonstrated with cell lines expressing HER oncogenes and an activatable IRF-1 fusion protein. Growth of cell lines expressing inactive HER1 is inhibited on IRF-1 activation. In contrast, the same cells are killed by apoptosis when HER1 and IRF-1 are activated simultaneously. We identified promoters stimulated synergistically by IRF-1 and by activated HER1. To determine the signals causing transcriptional synergism and/or apoptosis we tried to modulate these effects by various dominant negative acting proteins. Dominant negative STAT5α abolished both induction of apoptosis and transcriptional synergy of IRF-1 and HER. Thus, these results provide new insights into the mechanism of oncogene-dependent apoptosis induced by the activation of a tumor suppressor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- EGF:
-
Epidermal Growth Factor
- EGFR:
-
EGF Receptor
- HER:
-
Human Epidermal Growth Factor Receptor
- hER:
-
hormone binding domain of the human Estrogen Receptor
- PS:
-
Phosphatidyl Serine
- PI:
-
Propidium Iodide
- ISRE:
-
Interferon Stimulated Regulatory Element
- IRF-1:
-
Interferon Regulatory Factor 1
- STAT:
-
Signal Transducers and Activators of Transcription
- SH2:
-
Src Homology domain 2
- GAS:
-
γ-interferon Activated Sequence
- SRE:
-
STAT Responsive Element
- IRE:
-
IRF-1 Recognition Element
References
Angel P, Baumann I, Stein B, Delius H, Rahmsford HJ and Herrlich P. . 1987 Mol. Cell. Biol. 7: 2256–2266.
Artelt P, Morelle C, Ausmeier M, Fitzek M and Hauser H. . 1988 Gene 68: 213–219.
Attardi LD, Lowe SW, Brugarolas J and Jacks T. . 1996 EMBO J. 15: 3693–3701.
Baasner S, von Melchner H, Klenner T, Hilgard P and Beckers T. . 1996 Oncogene 13: 901–911.
Bacus SS, Zelnick CR, Plowman G and Yarden Y. . 1994 Am. J. Clin. Pathol. 102: 13–24.
Benech P, Vigneron M, Peretz D, Revel M and Chebath J. . 1987 Mol. Cell. Biol. 7: 4498–4504.
Biscardi JS, Belsches AP and Parsons SJ. . 1998 Mol. Carcinog. 21: 261–272.
Blochlinger K and Diggelmann H. . 1984 Mol. Cell. Biol. 4: 2929–2931.
Bovolenta C, Testolin L, Benussi L, Lievens PM-J and Liboi E. . 1998 J. Cell Biol. 273: 20779–20784.
Briken V, Ruffner H, Schultz U, Schwarz A, Reis LF, Strehlow I, Decker T and Staeheli P. . 1995 Mol. Cell. Biol. 15: 975–982.
Bromberg JF, Horvath CM, Besser D, Lathem WW and Darnell JE. . 1998 J. Cell Biol. 18: 2553–2558.
Chai SK, Nichols GL and Rothman P. . 1996 J. Immunol. 159: 4720–4728.
Chatterjee-Kishore M, Kishore R, Hicklin DJ, Marincola FM and Ferrone S. . 1998 J. Biol. Chem. 26: 16177–16183.
Chin YE, Kitagawa M, Kuida K, Flavell RA and Fu XY. . 1997 Mol. Cell. Biol. 17: 5328–5337.
Chon SY, Hassanian HH and Gupta SL. . 1996 J. Biol. Chem. 271: 17247–17252.
Colbère-Garapin F, Horodniceanu F, Khourilsky P and Garapin AC. . 1981 Mol. Biol. 150: 1–13.
Danial NN, Pernis A and Rothman PB. . 1995 Science 269: 1875–1877.
de Vries-Smits AM, Burgering BM, Leevers SJ, Marshall CJ and Bos JL. . 1992 Nature 357: 602–604.
de Wet JR, Wood KV, DeLuca M, Helinski DR and Subramani S. . 1987 Mol. Cell. Biol. 7: 725–737.
DiFiore PP, Pierce JH, Fleming TP, Hazan R, Ullrich A, King CR, Schlessinger J and Aaronson SA. . 1987 Cell 51: 1063–1070.
Dinter H and Hauser H. . 1987 Eur. J. Biochem. 166: 103–109.
Drew PD, Franzoso G, Becker KG, Bours V, Carlson LM, Siebenlist U and Ozato K. . 1995 J. Interferon Cytokine Res. 15: 1037–1045.
Duncan GS, Mittrucker HW, Kagi D, Matsuyama T and Mak TW. . 1996 J. Exp. Med. 184: 2043–2048.
Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC. . 1992 Cell 69: 119–128.
Fadok VA, Voelker DR, Campell PA, Cohen JJ, Bratton DL and Henson PM. . 1992 J. Immunol. 48: 2207.
Fujita T, Sakakibara J, Sudo Y, Miyamoto M, Kimura Y and Taniguchi T. . 1998 EMBO J. 7: 3397–3405.
Futaki M, Inokuchi K, Hanawa H, Tanosaki S, Dan K and Nomura T. . 1996 Leuk. Res. 20: 601–605.
Garcia R, Yu CL, Hudnall A, Catlett R, Nelson KL, Smithgall T, Fujita DJ, Ethier SP and Jove R. . 1997 Cell Growth Differ. 8: 1267–1276.
Graham F and van der Eb L. . 1973 Virology 52: 456–487.
Harada H, Kitagawa N, Tanaka N, Yamomoto H, Harada K, Ishihara M and Taniguchi T. . 1993 Science 259: 971–974.
Hobart M, Ramassar V, Goes N, Urmson J and Halloran PF. . 1996 Transplantation 62: 1895–1901.
Horiuchi M, Yamada T, Hayashida W and Dzau VJ. . 1997 J. Biol. Chem. 72: 11952–11958.
Hynes NE. . 1993 Semin. Cancer Biol. 4: 19–26.
Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, Le J, Koh SI, Kimura T, Green SJ, Mak T, Taniguchi T and Vilcek J. . 1994 Science 263: 1612–1615.
Karin M and Hunter T. . 1995 Curr. Biol. 5: 747–757.
Kirchhoff S, Schaper F and Hauser H. . 1993 Nucleic Acids Res. 21: 2881–2889.
Kirchhoff S, Koromilas AE, Schaper F, Grashoff M, Sonenberg N and Hauser H. . 1995 Oncogene 11: 439–445.
Kirchhoff S, Kröger A, Cruz H, Tümmler M, Schaper F, Köster M and Hauser H. . 1996 Cytotechnology 22: 147–156.
Kirchhoff S, Schaper F, Oumard A and Hauser H. . 1998 Biochimie in press.
Kroemer G. . 1995 Adv. Immunol. 58: 211.
Lew DJ, Decker T, Strehlow I and Darnell JE. . 1991 Mol. Cell. Biol. 11: 182–191.
Lohoff M, Ferrick D, Mittrucker HW, Duncan GS, Bischof S, Rollinghoff M and Mak TW. . 1997 Immunity 6: 681–689.
Lowe SW and Ruley HE. . 1993 Genes Dev. 7: 535–545.
Martin SJ, Reutelingsperger PM, McGahon AM, Rader JA, van Schie RC, LaFace DM and Green DR. . 1991 J. Exp. Med. 182: 1545.
Massa PT and Wu HJ. . 1995 Interferon Cytokine Res. 15: 799–810.
Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ and Baldwin Jr AS. . 1997 Science 278: 1812–1815.
Moriggl R, Gouilleux-Gruart V, Jahne R, Berchthold S, Gartmann C, Liu X, Henninghausen L, Sotiropoulos A, Groner B and Gouilleux F. . 1996 Mol. Cell. Biol. 16: 5691–5700.
Nguyen H, Lin R and Hiscott J. . 1997 Oncogene 15: 1425–1435.
Nicoletti I, Migliorati G, Pagliacci F, Grignani F and Riccardi C. . 1991 J. Immunol. Meth. 139: 271–279.
Ogasawara K, Hida S, Azimi N, Tagaya Y, Sato T, Yokochi-Fukuda T, Waldmann TA, Taniguchi T and Taki S. . 1998 Nature 391: 700–703.
Ohteki T, Yoshida H, Matsuyama T, Duncan GS, Mak TW and Ohashi PS. . 1998 J. Exp. Med. 187: 967–972.
Oie H, Gazdar AF, Buckler CE and Baron S. . 1977 J. Gen. Virol. 1: 107–109.
Park OK Schaefer TS and Nathans D. . 1996 Proc. Natl. Acad. Sci. USA 93: 13704–13708.
Pawson T. . 1994 Adv. Cancer Res. 64: 87–110.
Quelle FW, Thierfelder W, Witthuhn BA, Tang B, Cohen S and Ihle JN. . 1995 J. Biol. Chem. 270: 20775–20780.
Ruff-Jamison S, Chen K and Cohen S. . 1995 Proc. Natl. Acad. Sci. USA 92: 4215–4218.
Sala A, Casella I, Grasso L, Bellon T, Reed JC, Miyashita T and Peschle C. . 1996 Cancer Res. 56: 1991–1996.
Salkowski CA, Barber SA, Detore GR and Vogel SN. . 1996 J. Immunol. 156: 3107–3110.
Sambrook J, Fritsch EF and Maniatis T. . 1989 Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor: New York.
Schlessinger J and Ullrich A. . 1992 Neuron 2: 383–391.
Schneikert J, Peterziel H, Defoosez PA, Klocker H, Launoit Y and Cato AC. . 1996 J. Biol. Chem. 271: 23907–23913.
Shuai K, Halpern J, ten Hoeve J, Rao X and Sawyers CL. . 1996 Oncogene 13: 247–254.
Shual K, Ziemiecki A, Wilks AF, Harpur AG, Sadowski HB, Gilman MZ and Darnell JR. . 1993 Nature 366: 580–583.
Slamon DJ, Clark DM, Wong SG, Levin WJ, Ullrich A and McGuire WL. . 1987 Science 235: 177–182.
Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press MF. . 1989 Science 244: 707–712.
Takikawa O, Kuroiwa T, Yamazaki F and Kido R. . 1988 J. Biol. Chem. 263: 2041–2048.
Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S, Matsuyama T, Mak TW, Taki S and Taniguchi T. . 1995 Nature 376: 596–599.
Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S, Matsuyama T, Mak TW, Taki S and Taniguchi T. . 1997 Leukemia 11: 439–440.
Tan RS, Taniguchi T and Harada H. . 1996 Cancer Res. 56: 2417–2421.
Tanaka H and Samuel CE. . 1994 Proc. Natl. Acad. Sci. USA 91: 7995–7999.
Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, Matsuyama T, Lamphier MS, Aizawa S, Mak TW and Taniguchi T. . 1994a Cell 77: 829–839.
Tanaka N, Ishihara M and Taniguchi T. . 1994b Cancer Lett. 83: 191–196.
Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Matsuyama T, Mak TW, Aizawa S, Tokino T, Oren M and Taniguchi T. . 1996 Nature 382: 816–818.
Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfiled MD and Seeburg PH. . 1984 Nature 309: 418–425.
Ullrich A and Schlessinger J. . 1990 Cell 61: 203–212.
Vara J, Portela A, Ortin J and Jimenez A. . 1986 Nucleic Acids Res. 14: 4617–4624.
Verhoven B, Schlegel RA and Williamson P. . 1995 J. Exp. Med. 182: 1597.
Wang IM, Blanco JC, Tsai SY, Tsai MJ and Ozato K. . 1996 Mol. Cell. Biol. 16: 6313–6324.
White LC, Wright KL, Felix NJ, Ruffner H, Reis LF, Pine R and Ting JP. . 1996 Immunity 5: 365–376.
Yim JH, Wu SJ, Casey MJ, Norton JA and Doherty GM. . 1997 J. Immunol. 158: 1284–1292.
Zhong T, Wen Z and Darnell JE. . 1994 Science 264: 95–98.
Acknowledgements
We thank M Grashoff and M Höxter for excellent technical support. Dr T Beckers for the gift of NIH3T3 cells expressing HER1 or HER2. Dr H Rahmsdorf for an expression construct coding for rasAsn17. Dr M Göttlicher for the collagenase promoter constructs. Dr B Groner for the gift of the expression construct for STAT5αΔ750 and the STAT sensitive reporter construct. Dr L van der Eb for the DNAs coding for E1a/b. Drs PH Krammer and ME Peter for critical reading of the manuscript and helpful discussions. This work has been supported by BMBF grant no. 0310697.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kirchhoff, S., Hauser, H. Cooperative activity between HER oncogenes and the tumor suppressor IRF-1 results in apoptosis. Oncogene 18, 3725–3736 (1999). https://doi.org/10.1038/sj.onc.1202704
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202704
Keywords
This article is cited by
-
A murrel interferon regulatory factor-1: molecular characterization, gene expression and cell protection activity
Molecular Biology Reports (2014)
-
Combined gene expression and proteomic analysis of EGF induced apoptosis in A431 cells suggests multiple pathways trigger apoptosis
Apoptosis (2013)
-
Cooperative contributions of Interferon regulatory factor 1 (IRF1) and IRF8 to interferon-γ-mediated cytotoxic effects on oligodendroglial progenitor cells
Journal of Neuroinflammation (2011)
-
Influence of IFN-gamma and its receptors in human breast cancer
BMC Cancer (2007)
-
Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells
Oncogene (2007)